Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer

NCT00406276 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
28
Enrollment
OTHER
Sponsor class

Stopped data analysis showed insufficient drug efficacy

Conditions

Interventions

Sponsor

Emory University